Olema Pharmaceuticals, Inc.
OLMA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$42,217 | -$43,784 | -$30,389 | -$33,567 |
| Dep. & Amort. | $43 | $132 | $128 | $116 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $4,692 | $4,378 | $6,323 |
| Change in WC | $4,418 | $10,502 | -$16,282 | $2,176 |
| Other Non-Cash | $3,229 | -$1,425 | -$1,814 | -$1,332 |
| Operating Cash Flow | -$34,527 | -$29,883 | -$43,979 | -$26,284 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$71,652 | -$32,863 | -$142,855 | -$189,230 |
| Inv. Sales/Matur. | $88,925 | $67,097 | $97,772 | $74,806 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $17,273 | $34,234 | -$45,083 | -$114,424 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $41 | $0 | $222 | $243,501 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$2,518 | $0 | $799 |
| Financing Cash Flow | $41 | -$2,518 | $222 | $244,300 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$17,213 | $1,833 | -$88,840 | $103,592 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $52,473 | $50,640 | $139,480 | $35,888 |
| End Cash | $35,260 | $52,473 | $50,640 | $139,480 |
| Free Cash Flow | -$34,527 | -$29,883 | -$43,979 | -$26,284 |